top of page
Search

AI Inspection Readiness Matters: A Practical Playbook for Your GxP Systems

Writer: Rose Mary Aversa
Rose Mary Aversa
2 hours ago
3 min read

Artificial Intelligence is no longer just a buzzword for the future—it is already embedded in our manufacturing plants, quality systems, and lab environments. Yet, when it comes to regulatory scrutiny, a significant gap remains. The gap between rapid AI adoption and finalized regulatory guidance is exactly where compliance risk lives.


Here is the reality: regulators are not waiting for finalized guidance to ask hard questions. Inspectors are already asking, “How do you know this system is doing what you think it is?”. If an investigator walked into your facility tomorrow and asked to see your AI use cases, risk controls, and oversight records, where would you land?.


The Real Cost of AI Overreliance

If you think regulators are giving a free pass while they figure out AI, think again. The FDA has already issued Warning Letters concerning the inappropriate use of AI in GxP environments.


FDA Warning Letter Insight (April 2016) In a notable Warning Letter to Purolea Cosmetics Lab, the FDA cited the firm for utilizing AI agents to create drug product specifications, procedures, and master production records without human review. The FDA firmly stated: "If you use AI as an aid in document creation, you must review the AI generated documents to ensure they were accurate and actually compliant with CGMP.". Overreliance on AI without ensuring proper process validation led directly to a 21 CFR 211.22(c) violation.

Evaluating the AI Risk Profile: The Four Dimensions

Not all AI is created equal. The regulatory scrutiny your system will face depends heavily on its risk profile. To satisfy inspectors, critical thinking must be applied across four specific dimensions:


  • Dimension 1: Fundamental Capabilities. Is your sub-system deterministic (following strict, repeatable rules) or probabilistic (making predictive guesses based on patterns where the same input might yield different outputs)?.

  • Dimension 2: GxP Impact. What does the AI touch? You must evaluate its direct impact on patient safety, product quality, and critical data integrity.

  • Dimension 3: Data Quality and Availability. How good is the data driving the models? Is there enough accurate, representative data available to ensure reliable outputs?.

  • Dimension 4: Human Oversight. Who is in charge? You must distinguish between fully autonomous decision-making systems and decision-support systems. How effective is the human-in-the-loop oversight?.


The AI Inspection Readiness Playbook

Theoretical readiness won’t survive an audit. You need to be able to pull documented evidence instantly. We recommend adopting a Six-Element Playbook that creates a clear, shared path across the full system lifecycle and organizes system knowledge in one central reference:


  1. Define the Intended Use: Function of the AI system, distinguishing decision support from decision making, and mapping system interfaces.

  2. Govern the Data: Identifying GxP impact, mapping data flows, and establishing controls to ensure data integrity.

  3. Validation Document Structure: Organizing the Validation Plan, Model Cards, Development Data, explainability functions, and traditional V-model phases of risk, requirements, design, and tests.

  4. Manage Change & Release: Adapting traditional change management to address AI-specific changes like model updates and retraining.

  5. Monitor for Degradation (Drift): Establishing protocols to detect when model performance begins to drift from expected baselines over time.

  6. Control Access & Empower People: Ensuring the right individuals have appropriate system access and the knowledge required to oversee the AI effectively.


Expanding the Audit Room: The Four Key Roles

Inspection readiness requires tight choreography. IT cannot defend an AI system alone. To keep the audit accurate, focused, and consistent, four distinct Subject Matter Experts (SMEs) must be prepared to step into the audit room when called upon:


1. The Quality Unit


  • Their Role: Orchestrates how AI fits into the QMS and adapts validation policies. They explain the overarching controls and risk management.


  • What Inspectors Will Ask: How was AI incorporated into existing QMS policies? How is ongoing assurance maintained?.


2. Business / Process SME


  • Their Role: Validates how AI outputs support GxP decisions and dictates where human review occurs in daily operations.


  • What Inspectors Will Ask: How are AI outputs used to support or replace human GxP decisions? What happens when AI results don't align with expected outcomes?.


3. IT System SME


  • Their Role: Manages traditional data integrity, access controls, backups, and the technical architecture connecting the AI to other platforms.


  • What Inspectors Will Ask: How is data transferred, secured, and backed up? How are access controls and system availability managed?.


4. AI Sub-system SME


  • Their Role: A potentially new role involving data scientists or AI developers who understand model behavior, dataset curation, and algorithm performance.


  • What Inspectors Will Ask: What controls prevent bias in the model? How is retraining performed, and how is drift detected during routine use?.



Conclusion: Structure Drives Readiness


Structure puts you in control of your AI lifecycle, not just prepared for the next inspection. By classifying AI use cases by GxP impact, adopting a comprehensive lifecycle playbook, and preparing your distinct SME roles, your organization can confidently navigate the evolving regulatory landscape of artificial intelligence.



 
 
 

Comments

bottom of page